The STELARA® Dosing Difference

STELARA® is a prescription biologic with dosing specifically designed for Crohn’s disease.

Your STELARA® treatment starts with a one-time intravenous (IV) infusion that provides the amount of medication based on your body weight and is administered by a medical professional in a comfortable setting. Then you’ll receive, or self-administer, 90-mg maintenance injections given under the skin every 8 weeks to help keep your symptoms under control.

Your doctor will decide if your maintenance injections will be given at his or her office or if you’re ready to self-administer in the comfort of your own home.

 

See How STELARA® Dosing Stacks Up

First 52 Weeks of Therapy

Getting Started

Maintaining Treatment

STELARA® (ustekinumab)
1 IV Infusion
Week 0
6 Injections
6 Injections Graphic

Once every 8 weeks

STELARA® is a prescription medicine used to treat adults 18 years and older with moderately to severely active Crohn’s disease who have already taken other medicine that did not work well enough or they could not tolerate it.

Blocks interleukin 12 and interleukin 23 proteins involved in inflammatory and immune responses

HUMIRA®* (adalimumab)
6 Injections
6 Injections Graphic
25 Injections
25 Injections Graphic

Once every other week

HUMIRA® is a prescription medicine used to achieve and maintain clinical remission in adults who have not responded well to certain other medications. HUMIRA® is also used to reduce signs and symptoms and to achieve clinical remission in these adults who have lost response to or are unable to tolerate infliximab.

Blocks TNF-alpha proteins involved in inflammatory and immune responses

CIMZIA®* (certolizumab pegol)
6 Injections
6 Injections Graphic
24 Injections
24 Injections Graphic

Once every 4 weeks

CIMZIA® is a prescription medicine used in adult patients to lessen the signs and symptoms of moderately to severely active Crohn’s disease in patients who have not been helped enough by usual treatments.

Blocks TNF-alpha proteins involved in inflammatory and immune responses

STELARA® (ustekinumab)
1 IV Infusion
6 Injections

Given over at least one hour

Once every 8 weeks

STELARA® is a prescription medicine used to treat adults 18 years and older with moderately to severely active Crohn’s disease who have already taken other medicine that did not work well enough or they could not tolerate it.

Blocks interleukin 12 and interleukin 23 proteins involved in inflammatory and immune responses

HUMIRA®* (adalimumab)
6 Injections
25 Injections

Once every other week

HUMIRA® is a prescription medicine used to achieve and maintain clinical remission in adults who have not responded well to certain other medications. HUMIRA® is also used to reduce signs and symptoms and to achieve clinical remission in these adults who have lost response to or are unable to tolerate infliximab.

Blocks TNF-alpha proteins involved in inflammatory and immune responses

CIMZIA®* (certolizumab pegol)
6 Injections
24 Injections

Once every 4 weeks

CIMZIA® is a prescription medicine used in adult patients to lessen the signs and symptoms of moderately to severely active Crohn’s disease in patients who have not been helped enough by usual treatments.

Blocks TNF-alpha proteins involved in inflammatory and immune responses

*Indicated trademarks are registered trademarks of their respective owners.

 

While these factors are important, there are additional considerations for selecting treatment. Please talk to your doctor about treatment options and what might be right for you.

This presentation is not intended to compare the safety and effectiveness of these treatments. Please refer to each product’s full Prescribing Information for recommended dosing and administration.

The recommended treatment regimen for STELARA® is a single intravenous (IV) infusion of the amount of medication based on your body weight administered by a medical professional at week 0, followed by a 90-mg injection given under the skin as directed by your doctor at week 8 and then every 8 weeks thereafter. The injection is administered by a healthcare provider or self-injected only after proper training. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider.

Learn how eligible patients pay just $5 per dose for STELARA® medication costs.

 

Using commercial or private insurance to pay for your STELARA®?
Don't let cost get in the way of your medication costs if your doctor decides that STELARA® is right for you

$20,000 maximum program benefit per calendar year. Not valid for patients enrolled in Medicare, Medicare Part D, or Medicaid. Visit Stelara.JanssenCarePathSavings.com for full eligibility requirements.

 

Next: See How STELARA® Works